Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Opinion & Analysis Astrazeneca Ord Shs AZNCF

Healthcare
AstraZeneca PLC is a science-led biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of prescription medicines in oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory and immunology. Its pipeline forms a portfolio of investigational therapies in various stages of clinical development and... see more

Opinion & Analysis (OTCPK:AZNCF)

    Phase 3 trial for Inovio's VGX-3100 in cervical dysplasia gets FDA go-ahead

    The Life Sciences Report June 16, 2017

    Inovio moves forward on brain cancer and cancers caused by HPV; Zika and Ebola vaccines also advance

    The Life Sciences Report May 18, 2017

    What Andy Grove and Michael Milken have taught us about prostate cancer

    The Life Sciences Report April 20, 2016

    Circling the globe for uncommon biotech opportunities

    The Life Sciences Report February 18, 2016

    Buy biotech when there's blood on the street: Pontifax's Ran Nussbaum

    George S. Mack September 3, 2015

    O'Leary's O'Shares Triples The Size Of Its ETF Stable

    Benzinga.com  August 19, 2015

    Probe biotech's diverse subsectors for strong, undervalued companies: Van Leeuwenhoeck's Marcel Wijma

    Gail Dutton July 2, 2015

    Capitalize on comeback stories in micro-cap biotech: Joe Pantginis of ROTH Capital Partners

    George S. Mack June 17, 2015

    Frank Holmes: Health care sector spurred by population growth and M&As

    Frank Holmes  June 30, 2014

    Medical Device ETF In Focus As Medtronic Buys Covidien - ETF News And Commentary

    Benzinga.com  June 16, 2014

    ETF Outlook For Tuesday, April 29, 2014 (IHE, TAN, XRT, SOCL, TWTR)

    Benzinga.com  April 29, 2014

    Drug ETFs Surge On M&A Activity (AGN, VRX, IHE, XPH, PPH, AZN)

    Benzinga.com  April 22, 2014

    Cash in on the growing Chinese pharmaceutical market

    Tony D'Altorio September 10, 2010